(Q44779130)

6 December 2017

title

Tyrosine phosphatase inhibition augments collateral blood flow in a rat model of peripheral vascular disease (English)

1 reference

6 December 2017

Andrew N Carr

1

1 reference

6 December 2017

Michael G Davis

2

1 reference

6 December 2017

Elaine Eby-Wilkens

3

1 reference

6 December 2017

Brian W Howard

4

1 reference

6 December 2017

Bryan A Towne

5

1 reference

6 December 2017

Thomas E Dufresne

6

1 reference

6 December 2017

Kevin G Peters

7

1 reference

6 December 2017

publication date

26 February 2004

1 reference

American Journal of Physiology Heart and Circulatory Physiology

6 December 2017

published in

1 reference

6 December 2017

volume

287

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

H268-76

1 reference

Critical issues in peripheral arterial disease detection and management: a call to action

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Cloning and characterization of rat density-enhanced phosphatase-1, a protein tyrosine phosphatase expressed by vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Molecular mechanisms of blood vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Increase in receptor-like protein tyrosine phosphatase activity and expression level on density-dependent growth arrest of endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Meeting the challenge of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Arteriogenesis: the development and growth of collateral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Collateral arteries grow from preexisting anastomoses in the rat hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

HCPTPA, a protein tyrosine phosphatase that regulates vascular endothelial growth factor receptor-mediated signal transduction and biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Signaling--2000 and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Identification of Tek/Tie2 binding partners. Binding to a multifunctional docking site mediates cell survival and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Shear stress activates Tie2 receptor tyrosine kinase in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Protein tyrosine phosphatases in signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Regulation of receptor tyrosine kinase signaling by protein tyrosine phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Mechanism of insulin sensitization by BMOV (bis maltolato oxo vanadium); unliganded vanadium (VO4) as the active component

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Cell signaling by receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat--angiogenesis and angioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

An attempt to promote neo-vascularization by employing a newly synthesized inhibitor of protein tyrosine phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Angiopoietin-1 protects the adult vasculature against plasma leakage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Vanadium compounds biological actions and potential as pharmacological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Angiogenesis and arteriogenesis in limb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Protein tyrosine phosphatases: prospects for therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Protein tyrosine phosphatases: structure and function, substrate specificity, and inhibitor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Altered expression of protein-tyrosine phosphatase 2C in 293 cells affects protein tyrosine phosphorylation and mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

Regulation of angiogenesis by vascular endothelial growth factor and angiopoietin-1 in the rat aorta model: distinct temporal patterns of intracellular signaling correlate with induction of angiogenic sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00007.2004

10.1152/AJPHEART.00007.2004

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference